Cargando…

Loss of MAPK-activated protein kinase 2 enables potent dendritic cell-driven anti-tumour T cell response

Maintaining dendritic cells (DC) in a state of dysfunction represents a key mechanism by which tumour cells evade recognition and elimination by the immune system. Limited knowledge about the intracellular mediators of DC dysfunction restricts success of therapies aimed at reactivating a DC-driven a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Soukup, Klara, Halfmann, Angela, Dillinger, Barbara, Poyer, Fiona, Martin, Katharina, Blauensteiner, Bernadette, Kauer, Maximilian, Kuttke, Mario, Schabbauer, Gernot, Dohnal, Alexander M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5603533/ https://www.ncbi.nlm.nih.gov/pubmed/28924177 http://dx.doi.org/10.1038/s41598-017-12208-7

Ejemplares similares

PI3K Signaling in Dendritic Cells Aggravates DSS-Induced Colitis
por: Kuttke, Mario, et al.
Publicado: (2022)

CD28 Blockade Ex Vivo Induces Alloantigen-Specific Immune Tolerance but Preserves T-Cell Pathogen Reactivity
por: Dillinger, Barbara, et al.
Publicado: (2017)

Gliomasphere marker combinatorics: multidimensional flow cytometry detects CD44+/CD133+/ITGA6+/CD36+ signature
por: Erhart, Friedrich, et al.
Publicado: (2018)

Loss of JAK1 Drives Innate Immune Deficiency
por: Witalisz-Siepracka, Agnieszka, et al.
Publicado: (2019)

Protocol to assess the tolerogenic properties of adoptively transferred dendritic cells during murine experimental autoimmune encephalomyelitis
por: Vogel, Andrea, et al.
Publicado: (2022)

Myeloid PTEN deficiency impairs tumor-immune surveillance via immune-checkpoint inhibition
por: Kuttke, M., et al.
Publicado: (2016)

A pH‐sensitive Macromolecular Prodrug as TLR7/8 Targeting Immune Response Modifier
por: Aichhorn, Stefan, et al.
Publicado: (2017)

Dendritic cells are potent antigen-presenting cells for microbial superantigens
Publicado: (1992)

CTLA4-Ig immunosuppressive activity at the level of dendritic cell/T cell crosstalk
por: Mayer, Edda, et al.
Publicado: (2013)

Erratum: Sustained PI3K Activation exacerbates BLM-induced Lung Fibrosis via activation of pro-inflammatory and pro-fibrotic pathways
por: Kral, Julia Barbara, et al.
Publicado: (2016)

Sustained PI3K Activation exacerbates BLM-induced Lung Fibrosis via activation of pro-inflammatory and pro-fibrotic pathways
por: Kral, Julia Barbara, et al.
Publicado: (2016)

More than just protein building blocks: how amino acids and related metabolic pathways fuel macrophage polarization
por: Kieler, Markus, et al.
Publicado: (2021)

Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo
Publicado: (1996)

Murine epidermal Langerhans cells mature into potent immunostimulatory dendritic cells in vitro
Publicado: (1985)

Comparative evaluation of techniques for the manufacturing of dendritic cell-based cancer vaccines
por: Dohnal, Alexander Michael, et al.
Publicado: (2009)

Impact of MAPK Pathway Activation in BRAF(V600) Melanoma on T Cell and Dendritic Cell Function
por: Ott, Patrick A., et al.
Publicado: (2013)

B7-Dc, a New Dendritic Cell Molecule with Potent Costimulatory Properties for T Cells
por: Tseng, Su-Yi, et al.
Publicado: (2001)

Cell-permeable transgelin-2 as a potent therapeutic for dendritic cell-based cancer immunotherapy
por: Kim, Hye-Ran, et al.
Publicado: (2021)

Toll-Like Receptor 4 Engagement Drives Differentiation of Human and Murine Dendritic Cells from a Pro- into an Anti-Inflammatory Mode
por: Luger, Romana, et al.
Publicado: (2013)

Immunosuppressive peptides and their therapeutic applications()
por: Thell, Kathrin, et al.
Publicado: (2014)

Macrophage Rewiring by Nutrient Associated PI3K Dependent Pathways
por: Sharif, Omar, et al.
Publicado: (2019)

Dendritic Cells Promoted by Ginseng Saponins Drive a Potent Th1 Polarization
por: Takei, Masao, et al.
Publicado: (2008)

Determination of Extravasation Effects of Nal-Iri and Trabectedin and Evaluation of Treatment Options for Trabectedin Extravasation in a Preclinical Animal Model
por: Keritam, Omar, et al.
Publicado: (2022)

Clinical Adjuvant Combinations Stimulate Potent B-Cell Responses In Vitro by Activating Dermal Dendritic Cells
por: Matthews, Katie, et al.
Publicado: (2013)

Allogeneic dendritic cells induce potent antitumor immunity by activating KLRG1(+)CD8 T cells
por: Wang, Chao, et al.
Publicado: (2019)

TAP dysfunction in dendritic cells enables non-canonical cross-presentation for T cell priming
por: Barbet, Gaëtan, et al.
Publicado: (2021)

Human repair‐related Schwann cells adopt functions of antigen‐presenting cells in vitro
por: Berner, Jakob, et al.
Publicado: (2022)

Gene editing enables T-cell engineering to redirect antigen specificity for potent tumor rejection
por: Albers, Julian J, et al.
Publicado: (2019)

HSV-2 Cellular Programming Enables Productive HIV Infection in Dendritic Cells
por: Crisci, Elisa, et al.
Publicado: (2019)

Short-term cultured, interleukin-15 differentiated dendritic cells have potent immunostimulatory properties
por: Anguille, Sébastien, et al.
Publicado: (2009)

DNA vaccines targeting the encoded antigens to dendritic cells induce potent antitumor immunity in mice
por: Cao, Jun, et al.
Publicado: (2013)

Bordetella bronchiseptica is a potent and safe adjuvant that enhances the antigen-presenting capability of dendritic cells
por: Lee, You-Jeong, et al.
Publicado: (2020)

The CD85j(+) NK Cell Subset Potently Controls HIV-1 Replication in Autologous Dendritic Cells
por: Scott-Algara, Daniel, et al.
Publicado: (2008)

Specific targeting of whole lymphoma cells to dendritic cells ex vivo provides a potent antitumor vaccine
por: Adam, Christian, et al.
Publicado: (2007)

Dectin-1-activated dendritic cells trigger potent antitumour immunity through the induction of Th9 cells
por: Zhao, Yinghua, et al.
Publicado: (2016)

Macrophage phagocytosis of SARS-CoV-2-infected cells mediates potent plasmacytoid dendritic cell activation
por: García-Nicolás, O., et al.
Publicado: (2023)

NF-κB, p38 MAPK, ERK1/2, mTOR, STAT3 and increased glycolysis regulate stability of paricalcitol/dexamethasone-generated tolerogenic dendritic cells in the inflammatory environment
por: Dáňová, Klára, et al.
Publicado: (2015)

Cell-Cell Transmission Enables HIV-1 to Evade Inhibition by Potent CD4bs Directed Antibodies
por: Abela, Irene A., et al.
Publicado: (2012)

Dendritic cells loaded with CD44(+) CT-26 colon cell lysate evoke potent antitumor immune responses
por: Fu, Changhao, et al.
Publicado: (2019)

Apigenin, a potent suppressor of dendritic cell maturation and migration, protects against collagen‐induced arthritis
por: Li, Xing, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_2df1hh29blfa3js3svckrg2dnl